Editorial: New Advances in Non-small Cell Lung Cancer Management: Immune Modulation and Targeted Therapies

por Thierry Berghmans, Jacques Cadranel, Bogdan Grigoriu
Publicado 2021

Association of CSMD1 with Tumor Mutation Burden and Other Clinical Outcomes in Gastric Cancer

por Wang X, Wang S, Han Y, Xu M, Li P, Ke M, Teng Z, Huang P, Diao Z, Yan Y, Meng Q, Kuang Y, Zheng W, Liu H, Liu X, Jia B
Publicado 2021

Immunotherapy for the Treatment of Breast Cancer: Emerging New Data

por Mina LA, Lim S, Bahadur SW, Firoz AT
Publicado 2020

Cure the Incurable? Recent Breakthroughs in Immune Checkpoint Blockade for Hepatocellular Carcinoma

por Pei-Yi Chu, Shih-Hsuan Chan
Publicado 2021

Improving Immunotherapy Efficacy in Soft-Tissue Sarcomas: A Biomarker Driven and Histotype Tailored Review

por Matthieu Roulleaux Dugage, Elise F. Nassif, Antoine Italiano, Antoine Italiano, Rastislav Bahleda
Publicado 2021

Adverse Events Induced by PD-1/PD-L1 Inhibitors: A Real-World Single-Centre Experience with a Management-Based Approach

por Grimaud F, Penaranda G, Stavris C, Retornaz F, Brunel V, Cailleres S, Pegliasco H, Le Treut J, Grisoni V, Coquet E, Chiche L, Rognon A
Publicado 2021

Molecular genetic portrait of non-small cell lung cancer in Tambov region: regional experience

por N. A. Ognerubov, V. D. Sychev, N. A. Kozlova, V. L. Chang
Publicado 2020